Patients with NAFLD and incident diabetes had higher HOMA-IR values and higher fasting glucose, insulin, HbA1c, MCP-1 and MDA levels than patients with NAFLD alone and control subjects (Table 1, Figs. 1,2). This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatotic liver disease.